Prognostic value of myositis-specific antibodies in patients with idiopathic interstitial pneumonia
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Prognostic value of myositis-specific antibodies in patients with idiopathic interstitial pneumonia ; volume:24 ; number:1 ; day:10 ; month:10 ; year:2024 ; pages:1-8 ; date:12.2024
BMC pulmonary medicine ; 24, Heft 1 (10.10.2024), 1-8, 12.2024
- Creator
-
Wakabayashi, Hiroki
Iwasaki, Kotaro
Murakami, Yu
Takashima, Kenta
Kaneko, Kaichi
Matsuzawa, Yasuo
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-024-03326-w
- URN
-
urn:nbn:de:101:1-2412272121561.267664907921
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:28 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wakabayashi, Hiroki
- Iwasaki, Kotaro
- Murakami, Yu
- Takashima, Kenta
- Kaneko, Kaichi
- Matsuzawa, Yasuo
- SpringerLink (Online service)
Other Objects (12)
Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Utility of Anti-DSF70 antibodies to predict connective tissue disease in patients originally presenting with idiopathic interstitial pneumonia
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
Serum level of transforming growth factor-beta1 in major idiopathic interstitial pneumonia
Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
Myositis-specific antibodies: Overview and clinical utilization
Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What’s the diagnosis?
Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Utility of Anti-DSF70 antibodies to predict connective tissue disease in patients originally presenting with idiopathic interstitial pneumonia
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
Serum level of transforming growth factor-beta1 in major idiopathic interstitial pneumonia
Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
Myositis-specific antibodies: Overview and clinical utilization
Usual interstitial pneumonia coexisted with nonspecific interstitial pneumonia, What’s the diagnosis?
Role of anti-DFS70 antibodies in idiopathic interstitial pneumonia and in connective tissue disease associated interstitial lung disease
Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia
Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodies
Utility of Anti-DSF70 antibodies to predict connective tissue disease in patients originally presenting with idiopathic interstitial pneumonia
In adult onset myositis, the presence of interstitial lung disease and myositis specific/associated antibodies are governed by HLA class II haplotype, rather than by myositis subtype
Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review
Analytic Morphomics in Myositis-Related Interstitial Lung Disease
Expression of HSP47 in Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia
Serum level of transforming growth factor-beta1 in major idiopathic interstitial pneumonia
Correlation of monocyte counts with clinical outcomes in idiopathic nonspecific interstitial pneumonia
Myositis-specific antibodies: Overview and clinical utilization